Tildrakizumab for the treatment of exfoliative cheilitis
Authors : Timothy Cowan, Nada Abu Alrub, Anna Wilson, Mani Makhija, Dedee Murrell
Pages : 19-21
Doi:10.33204/mucosa.1209480
View : 12 | Download : 13
Publication Date : 2023-01-31
Article Type : Other
Abstract :Exfoliative cheilitis is an inflammatory condition that can significantly impair quality of life. This is the first reported case of an interleukin-23 inhibitor, tildrakizumab, for the treatment of a chronic, refractory case of exfoliative cheilitis.Keywords : biyolojik, keilit, tildrakizumab, interlökin-23, dermatoloji